… biologics (dupilumab, omalizumab, and mepolizumab) and … Omalizumab ranked second in
efficacy in terms of SNOT-22, … safety (AEs), dupilumab is the best choice and omalizumab is …

… perform a meta-analysis on safety. Besides FA, we also conducted a meta-analysis of RCTs
for AR and AA in the present study. This meta-analysis evaluated the efficacy and safety of …

… Since 2014, omalizumab has been approved for treatment of CSU in a few countries, and
evidence of its efficacy and safety has accumulated in recent years; 9 Omalizumab is the only …

… omalizumab remain controversial. Therefore, this study aims to estimate the efficacy and safety
of different doses of omalizumab … and safety of varying dosage levels of omalizumab in a …

… Given that there is no high-quality meta-analysis to incorporate existing evidence, the … and
meta-analysis of the level I evidence to ascertain whether omalizumab is beneficial and safe …

… omalizumab compared to placebo. However, the degree was mild to moderate. Conclusion:
This meta-analysis indicates that omalizumab is safe … efficacy and safety of omalizumab in …

… Furthermore, in our small cohort omalizumab had a reassuring safety profile. The most
interesting aspect of our study concerns the duration of the follow-up period, much longer than …

… statistical analysis, AI Papaioannou, S. Loukides, Myrto in both randomized controlled …
Omalizumab was administered by subcutaand safety of omalizumab therapy in severe allergic …

… The efficacy and safety of omalizumab were demonstrated in phase III clinical trials,
including its positive impact on asthma symptom management and control, exacerbations, …

… In the metanalyses, we combined the comparisons between omalizumab versus placebo in
the … Metanalysis shows a positive effect of omalizumab for achieving desensitization to the …